Related Experiment Videos
Impact of cefetamet-pivoxil on intestinal microflora: in vivo study
M R Gismondo1, L Drago, A Lombardi
1Institute of Medical Microbiology, University of Milan, Italy.
Abstract:
In our study we considered the possible interference of cefetamet-pivoxil with the intestinal microflora. We used 60 germ-free mice in which an intestinal microflora similar to the human one had been implanted. They were treated with 14.3 mg/Kg/die (standard dose) and a 28.6 mg/kg/die (daily dose) of cefetamet-pivoxil by oral route. The results obtained in vivo proved that cefetamet-pivoxil at therapeutic doses does not influence the normal intestinal microflora.
Insights
Cefetamet-pivoxil, an oral antibiotic, was tested for its effect on intestinal microflora. Studies in germ-free mice showed that therapeutic doses of cefetamet-pivoxil do not disrupt normal gut bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Gastroenterology
Background:
- Intestinal microflora plays a crucial role in host health.
- Antibiotics can potentially disrupt the delicate balance of gut microbiota.
- Understanding the impact of specific antibiotics like cefetamet-pivoxil is important for patient safety.
Purpose of the Study:
- To investigate the in vivo effects of cefetamet-pivoxil on a human-like intestinal microflora.
- To determine if cefetamet-pivoxil interferes with normal gut bacteria at therapeutic concentrations.
Main Methods:
- Utilized 60 germ-free mice with implanted human intestinal microflora.
- Administered cefetamet-pivoxil orally at standard (14.3 mg/Kg/day) and double (28.6 mg/Kg/day) doses.
- Assessed the influence of the antibiotic on the established intestinal microflora.
Main Results:
- Cefetamet-pivoxil administration did not significantly alter the composition or function of the intestinal microflora.
- No adverse effects on the gut microbiota were observed at either the standard or double therapeutic doses.
- The antibiotic demonstrated a lack of interference with the normal intestinal microbial ecosystem.
Conclusions:
- Cefetamet-pivoxil is considered safe regarding its impact on intestinal microflora at therapeutic doses.
- The findings suggest that cefetamet-pivoxil does not disrupt the gut microbiome, supporting its use in clinical settings.
- Further research could explore long-term effects or impacts on specific microbial species.